Lung Cancer Screening Eligibility Assessment

Study summary

The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedFramed Introductory Message A and Framed Introductory Message B

Plus 4 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 31, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Abramson Cancer Center at Penn Medicine

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Abramson Cancer Center at Penn Medicine
Interventions being studied: Behavioral: Framed Introductory Message A; Behavioral: Framed Introductory Message B; Behavioral: Framed Introductory Message C; Behavioral: Framed Tobacco Use Message A; Behavioral: Framed Tobacco Use Message B; Behavioral: Financial Incentive

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and 2. have completed at least one primary care visit at Penn Medicine in 2020-2025

Reasons someone may not be able to joinExclusion criteria

1. have a documented history of lung cancer; 2. have a documented history of completing LCS at Penn Medicine; 3. are listed as not wanting to be contacted or solicited for research; or 4. do not otherwise meet inclusion criteria.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of PennsylvaniaPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 31, 2025. Always confirm current availability with the study team.

View original record ↗